Zobrazeno 1 - 10
of 178
pro vyhledávání: '"Patorno, Elisabetta"'
Autor:
Tesfaye H; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Wang KM; Division of Renal (Kidney) Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Center for Healthcare Organization & Implementation Research (CHOIR), VA Boston Healthcare System, Boston, MA, USA., Zabotka LE; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Wexler DJ; MGH Diabetes Center, Division of Endocrinology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Schmedt N; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Koeneman L; Lilly Deutschland GmbH, Bad Homburg, Germany., Seman L; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA., Paik JM; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Division of Renal (Kidney) Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Center for Healthcare Organization & Implementation Research (CHOIR), VA Boston Healthcare System, Boston, MA, USA., Patorno E; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. epatorno@bwh.harvard.edu.
Publikováno v:
Journal of general internal medicine [J Gen Intern Med] 2024 Aug; Vol. 39 (10), pp. 1870-1879. Date of Electronic Publication: 2024 May 06.
Autor:
Yland JJ; Department of Epidemiology, Boston University School of Public Health, Boston, MA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA., Huybrechts KF; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA., Wesselink AK; Department of Epidemiology, Boston University School of Public Health, Boston, MA., Straub L; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA., Chiu YH; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.; CAUSALab, Harvard T.H. Chan School of Public Health, Boston, MA., Seely EW; Endocrinology, Diabetes and Hypertension Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA., Patorno E; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA., Bateman BT; Stanford University School of Medicine, Stanford, CA., Mogun H; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA., Wise LA; Department of Epidemiology, Boston University School of Public Health, Boston, MA., Hernández-Díaz S; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.; CAUSALab, Harvard T.H. Chan School of Public Health, Boston, MA.
Publikováno v:
Diabetes care [Diabetes Care] 2024 Jul 23. Date of Electronic Publication: 2024 Jul 23.
Autor:
Suissa K; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Schneeweiss S; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Glynn RJ; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Wexler DJ; Diabetes Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Suissa S; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.; Department of Medicine, McGill University, Montréal, Quebec, Canada., Paik JM; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Patorno E; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Jul 16. Date of Electronic Publication: 2024 Jul 16.
Autor:
Paik JM; Brigham and Women's Hospital, Boston, Massachusetts.; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Division of Renal (Kidney) Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Patorno E; Brigham and Women's Hospital, Boston, Massachusetts.; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Publikováno v:
JAMA internal medicine [JAMA Intern Med] 2024 Jul 01; Vol. 184 (7), pp. 852-853.
Autor:
Chiu YH; CAUSALab and Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (Y.-H.C., S.H.)., Huybrechts KF; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (K.F.H., E.P.)., Patorno E; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (K.F.H., E.P.)., Yland JJ; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts (J.J.Y.)., Cesta CE; Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden (C.E.C.)., Bateman BT; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California (B.T.B.)., Seely EW; Endocrinology, Diabetes and Hypertension Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (E.W.S.)., Hernán MA; CAUSALab, Department of Epidemiology, and Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (M.A.H.)., Hernández-Díaz S; CAUSALab and Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (Y.-H.C., S.H.).
Publikováno v:
Annals of internal medicine [Ann Intern Med] 2024 Jul; Vol. 177 (7), pp. 862-870. Date of Electronic Publication: 2024 Jun 18.
Autor:
Htoo PT; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Tesfaye H; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Schneeweiss S; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Wexler DJ; Massachusetts General Hospital Diabetes Center, Harvard Medical School, Boston, MA, USA., Everett BM; Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Glynn RJ; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Schmedt N; Global Epidemiology, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany., Koeneman L; Global Medical Affairs, Lilly Deutschland GmbH, Bad Homburg vor der Höhe, Germany., Déruaz-Luyet A; Global Epidemiology, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany., Paik JM; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Division of Renal (Kidney) Medicine, Brigham and Women's Hospital, Boston, MA, USA., Patorno E; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. epatorno@bwh.harvard.edu.
Publikováno v:
Diabetologia [Diabetologia] 2024 Jul; Vol. 67 (7), pp. 1328-1342. Date of Electronic Publication: 2024 Mar 21.
Autor:
Fu EL; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands., Wexler DJ; Diabetes Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Cromer SJ; Diabetes Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Bykov K; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Paik JM; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Division of Renal (Kidney) Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, MA, USA., Patorno E; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Publikováno v:
BMJ (Clinical research ed.) [BMJ] 2024 Jun 26; Vol. 385, pp. e078483. Date of Electronic Publication: 2024 Jun 26.
Autor:
Htoo PT; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., NajafZadeh M; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Tesfaye H; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Schneeweiss S; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Wexler DJ; Massachusetts General Hospital Diabetes Center, Harvard Medical School, Boston, MA., Glynn RJ; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Schmedt N; Global Epidemiology, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany., Déruaz-Luyet A; Global Epidemiology, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany., Koeneman L; Global Medical Affairs, Lilly Deutschland GmbH, Bad Homburg vor der Höhe, Germany., Paik JM; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Patorno E; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Publikováno v:
Diabetes care [Diabetes Care] 2024 Jun 25. Date of Electronic Publication: 2024 Jun 25.
Autor:
Omar AT; Division of Neurosurgery, Department of Surgery, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada omara29@mcmaster.ca.; Harvard University T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Division of Neurosurgery, St. Michael's Hospital, Toronto, Ontario, Canada., Diestro JDB; Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada., Spears J; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; Division of Neurosurgery, St. Michael's Hospital, Toronto, Ontario, Canada., Patorno E; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Journal of neurointerventional surgery [J Neurointerv Surg] 2024 Jun 05. Date of Electronic Publication: 2024 Jun 05.
Autor:
Skajaa N; From the Departments of Clinical Epidemiology and Clinical Medicine (N.S., K.L., H.T.S.), Aarhus University; Department of Clinical Biochemistry (K.L.), Aarhus University Hospital, Denmark; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine (J.C.L., E.P.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; and Yale School of Medicine (L.H.S.), New Haven, CT., Laugesen K; From the Departments of Clinical Epidemiology and Clinical Medicine (N.S., K.L., H.T.S.), Aarhus University; Department of Clinical Biochemistry (K.L.), Aarhus University Hospital, Denmark; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine (J.C.L., E.P.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; and Yale School of Medicine (L.H.S.), New Haven, CT., Lauffenburger JC; From the Departments of Clinical Epidemiology and Clinical Medicine (N.S., K.L., H.T.S.), Aarhus University; Department of Clinical Biochemistry (K.L.), Aarhus University Hospital, Denmark; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine (J.C.L., E.P.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; and Yale School of Medicine (L.H.S.), New Haven, CT., Schwamm LH; From the Departments of Clinical Epidemiology and Clinical Medicine (N.S., K.L., H.T.S.), Aarhus University; Department of Clinical Biochemistry (K.L.), Aarhus University Hospital, Denmark; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine (J.C.L., E.P.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; and Yale School of Medicine (L.H.S.), New Haven, CT., Sørensen HT; From the Departments of Clinical Epidemiology and Clinical Medicine (N.S., K.L., H.T.S.), Aarhus University; Department of Clinical Biochemistry (K.L.), Aarhus University Hospital, Denmark; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine (J.C.L., E.P.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; and Yale School of Medicine (L.H.S.), New Haven, CT., Patorno E; From the Departments of Clinical Epidemiology and Clinical Medicine (N.S., K.L., H.T.S.), Aarhus University; Department of Clinical Biochemistry (K.L.), Aarhus University Hospital, Denmark; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine (J.C.L., E.P.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; and Yale School of Medicine (L.H.S.), New Haven, CT.
Publikováno v:
Neurology [Neurology] 2024 May 14; Vol. 102 (9), pp. e209309. Date of Electronic Publication: 2024 Apr 22.